Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Packard

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
Journal of Internal Medicine|December 3, 2003
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic menJ Skogsberg, A D McMahon, F Karpe, et al.
Biochemical Pharmacology|October 15, 1988
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayersD J Kerr, S A Hynds, J Shepherd, et al.
Atherosclerosis|September 1, 1982
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsJ M Stewart, C J Packard, A R Lorimer, et al.
Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.
The Journal of Clinical Investigation|May 1, 1979
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolismJ Shepherd, C J Packard, J R Patsch, et al.
Artery|January 1, 1980
Combined drug therapy for familial hypercholesterolemiaC J Packard, J M Stewart, H G Morgan, et al.
Clinical Chemistry|October 1, 1982
High-density lipoprotein subfractions as measured by differential polyanionic precipitation and rate zonal ultracentrifugationH S Simpson, F C Ballantyne, C J Packard, et al.
Obstetrics and Gynecology|March 1, 1997
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosisN Sattar, A Bendomir, C Berry, et al.
Heart (British Cardiac Society)|February 18, 2004
Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudyI R Gunn, F K Maxwell, D Gaffney, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1988
Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, ScotlandJ J Series, E M Biggart, D S O'Reilly, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
Journal of Internal Medicine|December 3, 2003
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic menJ Skogsberg, A D McMahon, F Karpe, et al.
Biochemical Pharmacology|October 15, 1988
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayersD J Kerr, S A Hynds, J Shepherd, et al.
Atherosclerosis|September 1, 1982
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsJ M Stewart, C J Packard, A R Lorimer, et al.
Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.
The Journal of Clinical Investigation|May 1, 1979
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolismJ Shepherd, C J Packard, J R Patsch, et al.
Artery|January 1, 1980
Combined drug therapy for familial hypercholesterolemiaC J Packard, J M Stewart, H G Morgan, et al.
Clinical Chemistry|October 1, 1982
High-density lipoprotein subfractions as measured by differential polyanionic precipitation and rate zonal ultracentrifugationH S Simpson, F C Ballantyne, C J Packard, et al.
Obstetrics and Gynecology|March 1, 1997
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosisN Sattar, A Bendomir, C Berry, et al.
Heart (British Cardiac Society)|February 18, 2004
Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudyI R Gunn, F K Maxwell, D Gaffney, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1988
Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, ScotlandJ J Series, E M Biggart, D S O'Reilly, et al.
Pageof 24